Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikma Pharmaceuticals PLC
Other Equity Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
Other Equity
-$360m
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AstraZeneca PLC
LSE:AZN
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Verona Pharma PLC
NASDAQ:VRNA
Other Equity
-$4.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Other Equity
-$37m
CAGR 3-Years
-50%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Other Equity
-ÂŁ12.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hikma Pharmaceuticals PLC's Other Equity?
Other Equity
-360m USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's Other Equity amounts to -360m USD.

What is Hikma Pharmaceuticals PLC's Other Equity growth rate?
Other Equity CAGR 5Y
-8%

Over the last year, the Other Equity growth was -14%. The average annual Other Equity growth rates for Hikma Pharmaceuticals PLC have been -16% over the past three years , -8% over the past five years .

Back to Top